Cargando…

Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia

Identifying endophenotypes of schizophrenia is of critical importance and has profound implications on clinical practice. Here we propose an innovative approach to clarify the mechanims through which temperament and character deviance relates to risk for schizophrenia and predict long-term treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Molina, Juan L, Calvó, María, Padilla, Eduardo, Balda, Mara, Alemán, Gabriela González, Florenzano, Néstor V, Guerrero, Gonzalo, Kamis, Danielle, Rangeon, Beatriz Molina, Bourdieu, Mercedes, Strejilevich, Sergio A, Conesa, Horacio A, Escobar, Javier I, Zwir, Igor, Cloninger, C Robert, de Erausquin, Gabriel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226082/
https://www.ncbi.nlm.nih.gov/pubmed/28127577
http://dx.doi.org/10.1038/npjschz.2016.36
_version_ 1782493614358659072
author Molina, Juan L
Calvó, María
Padilla, Eduardo
Balda, Mara
Alemán, Gabriela González
Florenzano, Néstor V
Guerrero, Gonzalo
Kamis, Danielle
Rangeon, Beatriz Molina
Bourdieu, Mercedes
Strejilevich, Sergio A
Conesa, Horacio A
Escobar, Javier I
Zwir, Igor
Cloninger, C Robert
de Erausquin, Gabriel A
author_facet Molina, Juan L
Calvó, María
Padilla, Eduardo
Balda, Mara
Alemán, Gabriela González
Florenzano, Néstor V
Guerrero, Gonzalo
Kamis, Danielle
Rangeon, Beatriz Molina
Bourdieu, Mercedes
Strejilevich, Sergio A
Conesa, Horacio A
Escobar, Javier I
Zwir, Igor
Cloninger, C Robert
de Erausquin, Gabriel A
author_sort Molina, Juan L
collection PubMed
description Identifying endophenotypes of schizophrenia is of critical importance and has profound implications on clinical practice. Here we propose an innovative approach to clarify the mechanims through which temperament and character deviance relates to risk for schizophrenia and predict long-term treatment outcomes. We recruited 61 antipsychotic naïve subjects with chronic schizophrenia, 99 unaffected relatives, and 68 healthy controls from rural communities in the Central Andes. Diagnosis was ascertained with the Schedules of Clinical Assessment in Neuropsychiatry; parkinsonian motor impairment was measured with the Unified Parkinson’s Disease Rating Scale; mesencephalic parenchyma was evaluated with transcranial ultrasound; and personality traits were assessed using the Temperament and Character Inventory. Ten-year outcome data was available for ~40% of the index cases. Patients with schizophrenia had higher harm avoidance and self-transcendence (ST), and lower reward dependence (RD), cooperativeness (CO), and self-directedness (SD). Unaffected relatives had higher ST and lower CO and SD. Parkinsonism reliably predicted RD, CO, and SD after correcting for age and sex. The average duration of untreated psychosis (DUP) was over 5 years. Further, SD was anticorrelated with DUP and antipsychotic dosing at follow-up. Baseline DUP was related to antipsychotic dose-years. Further, ‘explosive/borderline’, ‘methodical/obsessive’, and ‘disorganized/schizotypal’ personality profiles were associated with increased risk of schizophrenia. Parkinsonism predicts core personality features and treatment outcomes in schizophrenia. Our study suggests that RD, CO, and SD are endophenotypes of the disease that may, in part, be mediated by dopaminergic function. Further, SD is an important determinant of treatment course and outcome.
format Online
Article
Text
id pubmed-5226082
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-52260822017-01-26 Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia Molina, Juan L Calvó, María Padilla, Eduardo Balda, Mara Alemán, Gabriela González Florenzano, Néstor V Guerrero, Gonzalo Kamis, Danielle Rangeon, Beatriz Molina Bourdieu, Mercedes Strejilevich, Sergio A Conesa, Horacio A Escobar, Javier I Zwir, Igor Cloninger, C Robert de Erausquin, Gabriel A NPJ Schizophr Article Identifying endophenotypes of schizophrenia is of critical importance and has profound implications on clinical practice. Here we propose an innovative approach to clarify the mechanims through which temperament and character deviance relates to risk for schizophrenia and predict long-term treatment outcomes. We recruited 61 antipsychotic naïve subjects with chronic schizophrenia, 99 unaffected relatives, and 68 healthy controls from rural communities in the Central Andes. Diagnosis was ascertained with the Schedules of Clinical Assessment in Neuropsychiatry; parkinsonian motor impairment was measured with the Unified Parkinson’s Disease Rating Scale; mesencephalic parenchyma was evaluated with transcranial ultrasound; and personality traits were assessed using the Temperament and Character Inventory. Ten-year outcome data was available for ~40% of the index cases. Patients with schizophrenia had higher harm avoidance and self-transcendence (ST), and lower reward dependence (RD), cooperativeness (CO), and self-directedness (SD). Unaffected relatives had higher ST and lower CO and SD. Parkinsonism reliably predicted RD, CO, and SD after correcting for age and sex. The average duration of untreated psychosis (DUP) was over 5 years. Further, SD was anticorrelated with DUP and antipsychotic dosing at follow-up. Baseline DUP was related to antipsychotic dose-years. Further, ‘explosive/borderline’, ‘methodical/obsessive’, and ‘disorganized/schizotypal’ personality profiles were associated with increased risk of schizophrenia. Parkinsonism predicts core personality features and treatment outcomes in schizophrenia. Our study suggests that RD, CO, and SD are endophenotypes of the disease that may, in part, be mediated by dopaminergic function. Further, SD is an important determinant of treatment course and outcome. Nature Publishing Group 2017-01-11 /pmc/articles/PMC5226082/ /pubmed/28127577 http://dx.doi.org/10.1038/npjschz.2016.36 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Molina, Juan L
Calvó, María
Padilla, Eduardo
Balda, Mara
Alemán, Gabriela González
Florenzano, Néstor V
Guerrero, Gonzalo
Kamis, Danielle
Rangeon, Beatriz Molina
Bourdieu, Mercedes
Strejilevich, Sergio A
Conesa, Horacio A
Escobar, Javier I
Zwir, Igor
Cloninger, C Robert
de Erausquin, Gabriel A
Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia
title Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia
title_full Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia
title_fullStr Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia
title_full_unstemmed Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia
title_short Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia
title_sort parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226082/
https://www.ncbi.nlm.nih.gov/pubmed/28127577
http://dx.doi.org/10.1038/npjschz.2016.36
work_keys_str_mv AT molinajuanl parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT calvomaria parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT padillaeduardo parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT baldamara parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT alemangabrielagonzalez parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT florenzanonestorv parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT guerrerogonzalo parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT kamisdanielle parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT rangeonbeatrizmolina parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT bourdieumercedes parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT strejilevichsergioa parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT conesahoracioa parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT escobarjavieri parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT zwirigor parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT cloningercrobert parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia
AT deerausquingabriela parkinsonianmotorimpairmentpredictspersonalitydomainsrelatedtogeneticriskandtreatmentoutcomesinschizophrenia